Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones

Dutchak, Paul A., Katafuchi, Takeshi, Bookout, Angie L., Choi, Jang Hyun, Yu, Ruth T., Mangelsdorf, David J., Kliewer, Steven A.·2012·Cell

Cited by (538)

Items 501–538 of 538

  1. Insulin signaling dynamics in human adipocytes : Mathematical modeling reveals mechanisms of insulin resistance in type 2 diabetes
    Elin Nyman · 2014 · Linköping University Electronic Press eBooks
  2. REGULATORS OF GLUCOSE AND LIPID METABOLISM IN SKELETAL MUSCLE AND SERUM IMPLICATIONS FOR OBESITY AND TYPE 2 DIABETES
    Fredirick L. Mashili · 2012 · Figshare
  3. Metabolic signaling under nutrient deprivation
    De Sousa Coelho, Ana Luisa · 2012 · TDX (Tesis Doctorals en Xarxa)
  4. Dual actions of figrowth factor 19 on lipid metabolism
    Xinle Wu, Hongfei Ge, Hélène Baribault, Jamila Gupte, Jennifer Weiszmann, Bryan D. Lemon, Jonitha Gardner, Preston Fordstrom, Jie Tang, Mingyue Zhou et al. · 2013
  5. Insulin signaling dynamics in human adipocytes
    Elin Nyman · 2014
  6. IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY
    Bethany Theresa Nelson · 2012
  7. Keystone Symposia, Genetic and Molecular Basis of Obesity and Body Weight Regulation (J7) , Pathogenesis of Diabetes (J8)に参加して
    Santa Fe Community · 2012
  8. Potensi Terapeutik Fibroblast Growth Factor 21 terhadap Resistensi Insulin
    Kurniasari Kurniasari, Wawaimuli Arozal · 2015 · eJournal Kedokteran Indonesia
  9. Molecular Regulators of Metabolism and Cardiometabolic Disease
    Indriyanti Rafi Sukmawati, Andi Wijaya · 2012 · The Indonesian Biomedical Journal
  10. Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated
    Xin-min Wu, Qi Feng · 2015
  11. Harnessing the Action of Fibroblast Growth Factor21 as a Therapeutic Agent
    Luigi Brunetti, Leonid Kagan · 2017 · Current Pharmacology Reports
  12. Towards Examining FGF21 Secretion from Pancreatic Islets in a Microfluidic Device
    Brenda J. Green · 2012 · TSpace (University of Toronto)
  13. Lipid Response to Amino Acid Starvation in Fat Cells: Role of FGF21
    Albert Pérez‐Martí, Pedro F. Marrero, Diego Haro, Joana Relat · 2017 · Springer eBooks
  14. Metabolic Values of Fibroblasts Growth Factor 21 in Patients with Coronary Artery Disease and Obesity
    Lyudmila M. Pasiyeshvili, K. Ivanova · 2018 · Ukraïnsʹkij žurnal medicini bìologìï ta sportu
  15. Fibroblast Growth Factor 21 is a Novel Protein Sensor in Pregnancy
    Elizabeth F. Sutton · 2017
  16. The role of growth factors in white fat browning and metabolic disease
    Carina Fischer · 2019 · Figshare
  17. Evidence of Browning Phenomenon and Its Physiological Relevance in Non-Adipose Tissues
    Derek Hoi-Hang Ho, Muralidhar Reddy Moola, Hong Lok Lung, Kwok-Hei Yau, Haze Yiu-Shuen Chan, Sze-Ngai Yuen, Patrick Ying‐Kit Yue, Roger Hoi-Fung Wong · 2019 · SSRN Electronic Journal
  18. Developmental signaling pathways in adult energy homeostasis
    Patrick J. Antonellis · 2021 · Figshare
  19. Growth Factors in the Human Body: A Conceptual Update
    Debasish Bandyopadhyay · 2019 · Cohesive Journal of Microbiology & Infectious Disease
  20. Faculty Opinions recommendation of PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity.
    Louis M. Weiss · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  21. Fatty Acid Metabolism during Exercise
    Takeshi Katafuchi, Makoto Makishima · 2021 · Journal of Nihon University Medical Association
  22. FGF21
    Tsz Wai Cheng, Po Sing Leung · 2017 · Springer eBooks
  23. Correlation of fibroblast growth factor 21 serum levels with metabolic parameters in Japanese subjects
    Qing‐Ri Jin, Yukiko Bando, Katsuyuki Miyawaki, Yosuke Shikama, Chisato Kosugi, Nanako Aki, Makoto Funaki, Sumihare Noji · 2000 · The Journal of Medical Investigation
  24. Role of Taurine Supplementation in Obesity: Stimulating Fats to Burn in Cellular Power Plants
    Reza Heidari, Mohammad Mehdi Ommati · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  25. Impact of 4-week endurance and resistance training on level of insulin resistance and FGf21 in heart tissue of diabetic male rats
    Sara Zare Karizak · 2024 · Comparative Clinical Pathology
  26. Hepatocyte FGF21 is not required for fasting-induced metabolic responses but guides protein appetite after energy depletion
    Justine Bruse, Clothilde Marbach, Arnaud Polizzi, Tatiana Landré, Juliette Salvi, Valérie Alquier‐Bacquie, Chen Shiou-Ping, Marine Huillet, Clémence Rives, Céline M.P. Martin et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Étude du rôle de la production hépatique de glucose dans le développement du diabète et de l’obésité
    Aya Abdul-Wahed · 2012 · theses.fr (ABES)
  28. Impact de la mutation G380R du récepteur FGFR3 responsable de l’achondroplasie sur le métabolisme énergétique et évaluation de l’effet d’un traitement par sFGFR3
    Céline Saint-Laurent · 2018
  29. Étude de la sensibilité à l’insuline du tissu adipeux en absence de production hépatique de glucose
    Sylvie Casteras · 2012
  30. Métabolisme redox et plasticité tissulaire des tissus adipeux
    Yannick Jeanson · 2015 · theses.fr (ABES)
  31. Rôle des FGFs endocrines et leurs récepteurs au cours de la fibrose pulmonaire idiopathique
    Mada Ghanem · 2023 · theses.fr (ABES)
  32. Inter-organ communication in physiology and pathophysiology : a role for the ChREBP-FGF21 axis?
    Thaïs Carbinatti · 2024 · theses.fr (ABES)
  33. Hepatic FGF21 is not required for fasting metabolism but guides protein appetite post energy depletion
    Justine Bruse, Clothilde Marbach, Arnaud Polizzi, Tatiana Landré, Juliette Salvi, Valérie Alquier‐Bacquie, Shiou-Ping Chen, Marine Huillet, Clémence Rives, Martin Céline et al. · 2026 · EMBO Reports
  34. Effects of exercise-induced myokines on rehabilitation and metabolic regulation
    Elif Zeynep ÖZTÜRK, Mehlika Alataş · 2026 · Journal of Health Sciences and Medicine
  35. Drug Development for MASH ‐Related Compensated Cirrhosis: Past, Present and Future
    Ren‐Qiang Zeng, Y C Shao, Ru-tao Lin, Xu-Ting Shen, Qinmei Sun, Xue Xin, Ping Liu, Jian‐Gao Fan, Yiyang Hu, Qin Feng · 2026 · Liver International
  36. GV-971 remodels the gut microbiota-bile acid-FXR axis to ameliorate obesity and metabolic dysfunction
    Na Zhang, Xinyu Ye, Kai Wang, Yameng Hu, Zixi Wang, Lichun Huang, Xi Chen, Ding Yan, Wen Fu, Qian Xue et al. · 2026 · Cell Discovery
  37. Pan-PPAR agonists: Emerging therapeutic strategies for metabolic dysfunction-associated steatotic liver disease
    Man Guo, Qi Wu, Chen-Hao Deng, Xiu‐Juan Jiang, J. H. Wang, Chen Zeng, Xiaozhen Tan, Fang‐Yuan Teng, Yong Liu, Yan Zeng et al. · 2026 · Metabolism
  38. Multi‐Tissue Crosstalk Regulating Meniscus Healing Under Inflammation and Physiological Loading
    Hun‐Jin Jeong, Elen Zhu, Min Seo Kang, Ming Wang, Samuel J. Comito, Chang Hun Lee · 2026 · Advanced Science